/

Empresas

Cu

No verificado

Curi Bio

Sobre qué escribimos

BiotecnologíaCienciaEventosFarmacéuticaSalud

10 Comunicados de prensa

Ver todos los comunicados de prensa

15/09/2026

FDA Accepts Curi Bio’s Letter of Intent into ISTAND Program to Qualify 3D Neuromuscular Junction Assay as a Non-Animal Replacement for Botulinum Toxin Potency Testing

Fuente

Editor

1.00

0

26/05/2026

Ciencia

Cardiología

Biología

Biotecnología

Farmacéutica

Salud

Eventos

Ferias y Congresos

Industria

Curi Bio Launches the Curiverse™ at MPS 2026: The Industry’s First Closed-Loop Ecosystem for Industrial-Scale, Human-Relevant Drug Discovery

Fuente

Editor

1.00

0

20/03/2026

Curi Bio and Battelle Announce Strategic Partnership to Accelerate the Adoption of New Approach Methods in Neuromuscular Pharmacology

Fuente

Editor

1.00

0

12/01/2026

Curi Bio Launches Asia-Pacific Hub, Delivering Greater Support to its Growing APAC Business

Fuente

Editor

1.00

0

02/12/2025

Curi Bio Secures $10M Series B to Scale Human-Relevant Preclinical Platforms and Advanced Data Analysis for Drug Discovery

Fuente

Editor

1.00

0

30/04/2025

Curi Bio and Cook MyoSite Announce Strategic Partnership

Fuente

Editor

1.00

0

08/04/2025

Biotecnología

Salud

Ciencia

Farmacéutica

Curi Bio Celebrates Grand Opening of New Global Headquarters in Seattle

Fuente

Editor

1.00

0

19/12/2024

Curi Bio Unlocks Advanced Cardiac Insights with Novoheart Integration

Fuente

Editor

1.00

0

22/11/2024

Multimedia

Biotecnología

Técnica

Asociaciones/Profesionales

Salud

Farmacéutica

Ciencia

Medicina - Varios

Eventos

Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner

Fuente

Editor

1.00

0

22/08/2024

Curi Bio’s Growth Propels Move to Prime Seattle Location to Advance Cutting-Edge Drug Discovery Research

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0